Back to Agenda
SESSION 7: ePI: Where are we?
Session Chair(s)
Imane Hattami
Therapeutic Area Head and Regulatory Policy Intelligence MEAR, Abbvie Biopharmaceuticals Gmbh, Morocco
Ronnie Mundair
Regional Labelling Head - Canada and LATAM - Senior Director, Pfizer, United Kingdom
Overview: In this session, we will hear from Industry Regulatory Experts and Regulators from the MENA region on regional insights, success stories and challenges, and how the adoption of the ePI can support the overall medicines ecosystem.
Speaker(s)
Ronnie Mundair
Regional Labelling Head - Canada and LATAM - Senior Director, Pfizer, United Kingdom
Where are we in the Middle East and where is ePI 1 year on?
Stefano Accorsi, MBA, MSC
Senior Director, Global Regulatory Affairs Policy, Intelligence and Affiliates, Chiesi Farmaceutici S.p.A., Italy
EFPIA IREG Survey Results: Conclusions & Recommendations
Bernhard Salb
Global Supply Chain Project Manager, Roche, Switzerland
How could Evolving Technology support Patients better and support the Industry and Regulators to offer much more when it comes to Product Information?
Ronnie Mundair
Regional Labelling Head - Canada and LATAM - Senior Director, Pfizer, United Kingdom
How could Evolving Technology support Patients better and support the Industry and Regulators to offer much more when it comes to Product Information?
Mohammed Abdelaal
Supervisor - Drug Registration & Pricing Section, Pharmacy & Drug Depart., Ministry of Public Health (MOPH), Qatar, Qatar
Panel Discussion with Q&A on the Basic Adoption of ePI and Digital Roadmap for ePI Adoption (with the additional participation of):
Mohammad Rabi, PHARMD
IT Specialist · Drug Directorate, Jordan Food and Drug Administration (JFDA), Jordan
Panel Discussion with Q&A on the Basic Adoption of ePI and Digital Roadmap for ePI Adoption (with the additional participation of):
Rehab Mehriz
Manager - General Administration of Pharmaceutical References & leaflets, Egyptian Drug Authority (EDA), Egypt
Panel Discussion with Q&A on the Basic Adoption of ePI and Digital Roadmap for ePI Adoption (with the additional participation of):
Lynsey Flitton
Director, Strategic Global Labeling, Europe, AbbVie, United Kingdom
Panel Discussion with Q&A on the Basic Adoption of ePI and Digital Roadmap for ePI Adoption (with the additional participation of):
Have an account?